VAPO - Vapotherm Inc Stock Price, Fair Value and News

$2.17

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

VAPO Price Action

Last 7 days

-0.5%

Last 30 days

0.9%

Last 90 days

163.4%

Trailing 12 Months

-35.7%

VAPO RSI Chart

VAPO Valuation

Market Cap

13.6M

Price/Earnings (Trailing)

-0.25

Price/Sales (Trailing)

0.19

EV/EBITDA

-0.42

Price/Free Cashflow

-0.65

VAPO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

VAPO Fundamentals

VAPO Revenue

Revenue (TTM)

70.9M

Rev. Growth (Yr)

5.28%

Rev. Growth (Qtr)

-11.76%

VAPO Earnings

Earnings (TTM)

-54.4M

Earnings Growth (Yr)

3.5%

Earnings Growth (Qtr)

3.81%

VAPO Profitability

Operating Margin

46.74%

EBT Margin

-76.57%

Return on Equity

66.92%

Return on Assets

-80.12%

Free Cashflow Yield

-154.67%

VAPO Investor Care

Shares Dilution (1Y)

1.81%

Diluted EPS (TTM)

-8.36

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	70.1M	70.9M	0	0
2023	62.9M	66.0M	67.6M	68.7M
2022	102.6M	95.0M	70.4M	66.8M
2021	138.9M	124.4M	132.0M	113.3M
2020	54.9M	78.1M	97.8M	125.7M
2019	43.9M	45.4M	46.8M	48.1M
2018	0	0	0	42.4M

Get all data in R, Python etc through our Historical Stock Data APIs

About Vapotherm Inc

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

CEO	Mr. Joseph F. Army CPA, CPA
WEBSITE	vapotherm.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	261

Vapotherm Inc Frequently Asked Questions

What is the ticker symbol for Vapotherm Inc? What does VAPO stand for in stocks?

VAPO is the stock ticker symbol of Vapotherm Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Vapotherm Inc (VAPO)?

As of Thu Sep 19 2024, market cap of Vapotherm Inc is 13.55 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VAPO stock?

You can check VAPO's fair value in chart for subscribers.

Is Vapotherm Inc a good stock to buy?

The fair value guage provides a quick view whether VAPO is over valued or under valued. Whether Vapotherm Inc is cheap or expensive depends on the assumptions which impact Vapotherm Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VAPO.

What is Vapotherm Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Sep 19 2024, VAPO's PE ratio (Price to Earnings) is -0.25 and Price to Sales (PS) ratio is 0.19. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VAPO PE ratio will change depending on the future growth rate expectations of investors.